Terms: = Breast cancer AND CALCB, Calcitonin AND Diagnosis
34 results:
1. Preoperative comprehensive malignancy risk estimation for thyroid nodules: Development and verification of a network-based prediction model.
Shao G; Sun B; Shi M; Song Y; Sun Z; Hao X; Li L; Fu Z
Eur J Surg Oncol; 2022 Jun; 48(6):1264-1271. PubMed ID: 35367109
[TBL] [Abstract] [Full Text] [Related]
2. Unexpected Pathogenic RET p.V804M Variant Leads to the Clinical diagnosis and Management of Medullary Thyroid Carcinoma.
Ghazani AA; Breen KM; Dwan M; Barletta JA; Vatnick DR; Stokes SM; Block C; Doherty GM; Cohn AY; Marqusee E; Garber JE; Rana HQ
Am J Case Rep; 2020 Dec; 21():e927415. PubMed ID: 33361738
[TBL] [Abstract] [Full Text] [Related]
3. breast metastasis from medullary thyroid carcinoma mimicking ductal carcinoma with neuroendocrine differentiation.
Laforga JB; Dominguez E; Aranda FI
Cancer Rep (Hoboken); 2020 Dec; 3(6):e1292. PubMed ID: 33025739
[TBL] [Abstract] [Full Text] [Related]
4. Medullary carcinoma of thyroid metastasis to breast: A cytological experience.
Devi CA; Stephen SN; Gochhait D; Shanmugam D; Dharanipragada K; Siddaraju N; Singh D
Diagn Cytopathol; 2020 Feb; 48(2):169-173. PubMed ID: 31782260
[TBL] [Abstract] [Full Text] [Related]
5. Genetic analysis of a hereditary medullary thyroid carcinoma case with normal preoperative serum calcitonin levels.
Zhang G; Jiang Y; Zhang S; Zhao L; Fan J; Zhang Z; Ma J; Chen R; Xu Y
Pathol Res Pract; 2019 Oct; 215(10):152529. PubMed ID: 31409511
[TBL] [Abstract] [Full Text] [Related]
6. Medullary thyroid carcinoma with breast metastasis: Two case reports.
Meng K; Chen W; Tian W; Sun K; Chen H
Medicine (Baltimore); 2018 Nov; 97(47):e13193. PubMed ID: 30461619
[TBL] [Abstract] [Full Text] [Related]
7. Solid Cell Nests Within a Parathyroid Gland-Report of an Exceptional Case.
Juhlin CC; Nilsson IL; Höög A
Endocr Pathol; 2018 Dec; 29(4):365-368. PubMed ID: 30003532
[TBL] [Abstract] [Full Text] [Related]
8. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
Martins A; Gonçalves A; Almeida T; Midões A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
[TBL] [Abstract] [Full Text] [Related]
9. Initial clinical presentation of single soft tissue metastasis of medullary thyroid carcinoma without primary tumor in the thyroid gland.
Okamoto M; Takazawa A; Aoki K; Yoshimura Y; Kato H; Otsuki T; Maeno K; Koizumi T
World J Surg Oncol; 2017 Dec; 15(1):221. PubMed ID: 29237502
[TBL] [Abstract] [Full Text] [Related]
10. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
Hassan A; Siddiqui M; Jahangir S
Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
[TBL] [Abstract] [Full Text] [Related]
11. A calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.
Kasajima A; Cameselle-Teijeiro J; Loidi L; Takahashi Y; Nakashima N; Sato S; Fujishima F; Watanabe M; Nakazawa T; Naganuma H; Kondo T; Kato R; Sasano H
Endocr Pathol; 2016 Dec; 27(4):325-331. PubMed ID: 26860935
[TBL] [Abstract] [Full Text] [Related]
12. Metastatic medullary thyroid carcinoma to the breast in a patient with combined medullary and papillary carcinoma of thyroid--a case report.
Alath P; Ahmed IN; Al-Jassar A; Hussein S; Amir T; Al-Waheeb S; Al-Abdulghani R; George SS; Kapila K
Diagn Cytopathol; 2015 Apr; 43(4):343-8. PubMed ID: 25350779
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid metastases from a breast cancer diagnosed by fine-needle aspiration biopsy. Case report and overview of the literature.
Lacka K; Breborowicz D; Uliasz A; Teresiak M
Exp Oncol; 2012 Jul; 34(2):129-33. PubMed ID: 23013767
[TBL] [Abstract] [Full Text] [Related]
14. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
Becker KL; Snider R; Nylen ES
Br J Pharmacol; 2010 Jan; 159(2):253-64. PubMed ID: 20002097
[TBL] [Abstract] [Full Text] [Related]
15. [The treatment of medullary thyroid cancer].
Fujita T; Fujimori M
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021
[TBL] [Abstract] [Full Text] [Related]
16. cancer-treatment-induced bone loss, part 2.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(6):534-46. PubMed ID: 16522890
[TBL] [Abstract] [Full Text] [Related]
17. cancer-treatment-induced bone loss, part 1.
Michaud LB; Goodin S
Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
[TBL] [Abstract] [Full Text] [Related]
18. cancer treatment-induced bone loss in patients with breast or prostate cancer.
Maxwell C; Viale PH
Oncol Nurs Forum; 2005 May; 32(3):589-603. PubMed ID: 15897934
[TBL] [Abstract] [Full Text] [Related]
19. Abnormal distribution and hyperplasia of thyroid C-cells in PTEN-associated tumor syndromes.
Zambrano E; Holm I; Glickman J; Huang S; Perez-Atayde A; Kozakewich HP; Shamberger RC; Nosé V
Endocr Pathol; 2004; 15(1):55-64. PubMed ID: 15067177
[TBL] [Abstract] [Full Text] [Related]
20. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
[TBL] [Abstract] [Full Text] [Related]
[Next]
